USP1 and Miyoshi myopathy: SJB3-019A is a selective inhibitor of USP1, which can decrease cell viability, trigger apoptosis, overcome bortezomib resistance in MM cells, and down-regulate renewal/survival related proteins and even promote MM stem cells differentiation [139].